The global cyclosporine market, valued at USD 4.22 billion in 2024, is anticipated to expand at a CAGR of 5.3% from 2025 to 2034. This growth trajectory is being shaped by a complex interplay of regional manufacturing trends, cross-border supply chain dynamics, and evolving regulatory frameworks that are redefining market access and production strategies. Cyclosporine, a critical...